Search results
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron,...
Benzinga· 2 days agoStructure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290,...
Heart disease is the top cause of death in the U.S., and more than 60% of Americans will have it by...
PhillyVoice.com· 14 hours agoHeart disease kills about 800,000 Americans each year and is the leading cause of death. A continued...
Gary Brecka on obesity, Sweet Truth Act signed by Eric Adams: 'We are addicted to how sugar makes us...
AOL· 14 hours agoLate last year, Mayor Eric Adams signed the Sweet Truth Act, which will require chain restaurants to conspicuously express warnings next to menu items with high volumes of added sugar and, beginning ...
At least 6 in 10 U.S. adults will have cardiovascular disease in the next 30 years, new study finds....
Yahoo Life Style via AOL· 1 day agoCardiologists break it down. Why are cardiovascular disease cases rising? There are several reasons...
Heart disease and stroke could affect at least 60% of adults in U.S. by 2050
Stamford Advocate· 17 hours agoThe projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 ...
Heart disease and stroke could affect at least 60% of adults in U.S. by 2050
San Francisco Chronicle· 17 hours agoThe projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 ...
Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancer
Daily Express· 18 hours agoWeight loss jabs such as Ozempic have “enormous potential” as a new weapon in the fight against...
Seeking social media for medical advice could put your health at risk
WIBW Topeka· 11 hours agoA 2022 report from the Centers for Disease Control and Prevention (CDC) found 22 states have an adult obesity rate at or above 35%. The latest making the ...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters via AOL· 2 days ago(Reuters) -Structure Therapeutics said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations ...
Arrowhead shares hold Outperform rating By Investing.com
Investing.com· 6 days agoThe CEO highlighted the anticipation for forthcoming data on familial chylomicronemia syndrome (FCS)...